MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the company’s chairman and CEO, Gary Rabin, will be presenting at two upcoming conferences: the Rodman & Renshaw 13th Annual Healthcare Conference in New York and Terrapinn’s Stem Cells USA & Regenerative Medicine Congress 2011 in Boston. Mr. Rabin will provide updates on the company’s two ongoing human clinical trials using hESC-derived RPE cells to treat macular degeneration and other programs.
